Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylation
暂无分享,去创建一个
[1] A. Shisheva,et al. A cytosolic protein tyrosine kinase in rat adipocytes , 1992, FEBS letters.
[2] J. McNeill,et al. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. , 1985, Science.
[3] B. Geiger,et al. Modulation of intercellular adherens-type junctions and tyrosine phosphorylation of their components in RSV-transformed cultured chick lens cells. , 1991, Cell regulation.
[4] S. Pugazhenthi,et al. Long-term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice. , 1991, Metabolism: clinical and experimental.
[5] M. Cobb,et al. Extracellular signal-regulated kinases: ERKs in progress. , 1991, Cell regulation.
[6] M. Davidson,et al. Antidiabetic Action of Vanadyl in Rats Independent of in Vivo Insulin-Receptor Kinase Activity , 1991, Diabetes.
[7] Y. Zick,et al. The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. , 1990, The Journal of biological chemistry.
[8] Philip R. Cohen,et al. MAP kinase activator from insulin‐stimulated skeletal muscle is a protein threonine/tyrosine kinase. , 1992, The EMBO journal.
[9] T. Dull,et al. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. , 1987, The Journal of biological chemistry.
[10] G. Swarup,et al. Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. , 1982, Biochemical and biophysical research communications.
[11] Y. Zick,et al. The insulin receptor: structure and function. , 1989, Critical reviews in biochemistry and molecular biology.
[12] C. Kahn,et al. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells , 1985, Nature.
[13] R. Davis,et al. Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. , 1993, The Journal of biological chemistry.
[14] W. Rutter,et al. The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells. , 1992, The Biochemical journal.
[15] Y. Zick,et al. pp75: A novel tyrosine-phosphorylated protein that heralds differentiation of HL-60 cells. , 1991, The Journal of biological chemistry.
[16] R. Campos-González,et al. Tyrosine phosphorylation of mitogen-activated protein kinase in cells with tyrosine kinase-negative epidermal growth factor receptors. , 1992, The Journal of biological chemistry.
[17] Y. Yazaki,et al. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine. , 1992, The Journal of biological chemistry.
[18] S. Brichard,et al. Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa/fa rats. , 1989, Endocrinology.
[19] A. Ullrich,et al. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. , 1987, The Journal of biological chemistry.
[20] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[21] K. Guan,et al. Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-induced Thr/Tyr protein phosphatase. , 1993, The Journal of biological chemistry.
[22] J. Olefsky. The Insulin Receptor: A Multifunctional Protein , 1990, Diabetes.
[23] A. Srivastava,et al. Regulation of a rat lung protein tyrosine kinase activity by reversible phosphorylation/dephosphorylation , 1988, FEBS letters.
[24] T. Hunter,et al. Detection and quantification of phosphotyrosine in proteins. , 1983, Methods in enzymology.
[25] C. Kahn,et al. Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.
[26] S. Pelech,et al. MAP kinases: charting the regulatory pathways. , 1992, Science.
[27] David L. Brautigan,et al. Raf-1 activates MAP kinase-kinase , 1992, Nature.
[28] C. Kahn,et al. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. , 1982, Science.
[29] Y. Zick,et al. A combination of H2O2 and vanadate concomitantly stimulates protein tyrosine phosphorylation and polyphosphoinositide breakdown in different cell lines. , 1990, Biochemistry.
[30] P. Vicario,et al. The insulin-mimetic effect of vanadate is not correlated with insulin receptor tyrosine kinase activity nor phosphorylation in mouse diaphragm in vivo. , 1989, Endocrinology.
[31] S. Tamura,et al. A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. , 1984, The Journal of biological chemistry.
[32] Y. Shechter. Insulin-Mimetic Effects of Vanadate: Possible Implications for Future Treatment of Diabetes , 1990, Diabetes.
[33] J. McDonald,et al. Vanadyl and vanadate inhibit Ca2+ transport systems of the adipocyte plasma membrane and endoplasmic reticulum. , 1985, Archives of biochemistry and biophysics.
[34] S. Brichard,et al. Marked Improvement of Glucose Homeostasis in Diabetic ob/ob Mice Given Oral Vanadate , 1990, Diabetes.
[35] M. Villereal,et al. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. , 1992, The Journal of biological chemistry.
[36] J. Casnellie,et al. The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation. , 1989, Endocrinology.
[37] I. G. Fantus,et al. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. , 1989, Biochemistry.
[38] J. Tavaré,et al. Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations. , 1992, The Biochemical journal.